From osteoporosis and osteoarthritis to sarcopenia, BMP signaling is emerging as one of the most important regulators of musculoskeletal health—and a promising therapeutic target.
For most clinicians, bone morphogenetic proteins (BMPs) are synonymous with spinal fusion or difficult fracture repair. Recombinant BMP-2 has been used in orthopedic surgery for years, primarily because of its powerful ability to stimulate bone formation. But that traditional view is rapidly expanding.
A comprehensive review recently published in the Journal of Orthopaedic Translation suggests that BMP signaling is far more than a bone-building pathway. Instead, it functions as a master regulator of the entire musculoskeletal system, influencing bone remodeling, cartilage integrity, muscle regeneration, tendon healing, inflammation, and stem cell differentiation. Even more intriguing, BMP signaling appears to communicate extensively with other pathways familiar to functional medicine clinicians, including Wnt/β-catenin, TGF-β, MAPK, PI3K/Akt, and mTOR.
As our understanding of these interactions grows, BMP biology may become central to future strategies for preventing—and potentially reversing—the progression of age-related musculoskeletal disease.
More Than “Bone Proteins”
BMPs belong to the transforming growth factor-beta (TGF-β) superfamily and were originally identified because of their remarkable ability to induce new bone formation. Since then, researchers have identified more than 20 BMP family members with diverse biological functions extending far beyond the skeleton.
Today we know these signaling molecules regulate:
- Osteoblast and osteoclast activity
- Mesenchymal stem cell differentiation
- Cartilage maintenance
- Muscle satellite cell activation
- Tendon repair
- Fracture healing
- Developmental tissue patterning
Rather than acting as isolated growth factors, BMPs function as part of an intricate signaling network that determines cellular fate throughout the musculoskeletal system.
A comprehensive review recently published in the Journal of Orthopaedic Translation suggests that BMP signaling is far more than a bone-building pathway. Instead, it functions as a master regulator of the entire musculoskeletal system, influencing bone remodeling, cartilage integrity, muscle regeneration, tendon healing, inflammation, and stem cell differentiation.
Maintaining Bone Homeostasis
Healthy bone is anything but static. Throughout life, bone continuously remodels itself through the balanced activity of osteoblasts, which build bone, and osteoclasts, which remove damaged tissue. BMP signaling plays an essential role in coordinating this balance.
Interestingly, BMP activity is highly dose dependent. Lower concentrations help recruit precursor cells involved in bone remodeling, while higher concentrations influence osteoclast behavior differently. BMPs also regulate the critical RANKL/osteoprotegerin (OPG) signaling system that controls bone resorption. The result is a tightly regulated system designed to maintain skeletal integrity throughout life.
Osteoporosis: Restoring the Balance
Osteoporosis develops when bone resorption begins to outpace bone formation.
The review highlights multiple BMP family members—including BMP-2, BMP-4, BMP-7, BMP-6, and BMP-9—as regulators of osteoblast differentiation and bone regeneration. In numerous experimental models, enhancing BMP signaling improved bone mineral density, increased trabecular bone volume, stimulated osteoblast activity, and reduced bone loss.
BMP-2, in particular, appears capable of shifting mesenchymal stem cells away from adipocyte formation and toward osteoblast development by influencing transcription factors such as Runx2 while suppressing PPARγ signaling. This finding is especially relevant because aging bone marrow tends to accumulate fat at the expense of bone-forming cells.
However, the story is not entirely straightforward. Some human studies have reported impaired BMP responsiveness in osteoporotic osteoblasts, suggesting that simply increasing BMP levels may not always restore healthy signaling. Timing, receptor function, and the broader cellular environment likely determine whether BMP stimulation produces beneficial or undesirable effects.
For more in-depth coverage of BMPs, visit our Regenerative Health & Medicine Resource Center, which includes relevant podcast and webinar links.
Osteoarthritis: Repairing Cartilage—or Accelerating Degeneration?
Perhaps the most fascinating aspect of BMP biology is its dual role in osteoarthritis (OA).
Cartilage degeneration is the hallmark of OA, and BMP signaling clearly participates in maintaining extracellular matrix homeostasis and chondrocyte function. In many experimental studies, BMP-2 increases collagen type II expression while reducing cartilage-degrading enzymes such as MMP-13, suggesting a protective role for cartilage preservation.
Researchers also found that BMP-2:
- Improves mitochondrial metabolism in chondrocytes
- Enhances oxidative phosphorylation
- Supports cartilage-specific gene expression
- Promotes differentiation of stem cells into cartilage-producing cells
- Improves repair of cartilage defects in animal models
Yet excessive BMP activity may produce the opposite effect. Other studies cited in the review demonstrate that elevated BMP signaling can promote chondrocyte hypertrophy, cartilage remodeling, inflammatory cytokine production, and abnormal bone formation within osteoarthritic joints.
This reinforces an increasingly common theme in regenerative medicine: The question is often not whether a pathway is “good” or “bad,” but whether it is activated at the right time, in the right tissue, and at the appropriate intensity.
BMPs and Muscle: An Underappreciated Relationship
Many clinicians think of BMPs exclusively as bone molecules. In reality, skeletal muscle is also heavily influenced by BMP signaling.
The review describes how BMPs regulate satellite cell activation, muscle regeneration, protein synthesis, and muscle growth throughout life. BMP activation stimulates Smad 1/5/8 signaling, which enhances mTOR activity and promotes protein synthesis while simultaneously suppressing pathways responsible for muscle protein breakdown. Conversely, blocking BMP signaling after muscle injury results in smaller regenerated muscle fibers and impaired recovery. This has significant implications for sarcopenia.
Rather than viewing age-related muscle loss solely through the lens of protein intake or resistance exercise, future therapies may aim to optimize anabolic signaling pathways such as BMP while simultaneously reducing catabolic drivers.
Crosstalk Changes Everything
Perhaps the most important takeaway from this review is that BMPs rarely work alone. The pathway interacts continuously with numerous signaling networks that functional medicine clinicians already recognize as central regulators of aging and chronic disease. These include:
- Wnt/β-catenin
- TGF-β
- PI3K/Akt
- MAPK
- YAP/TAZ
- mTOR
- NF-κB
- FoxO signaling
This extensive crosstalk helps explain why interventions targeting only one pathway often produce inconsistent results. Musculoskeletal aging is increasingly understood as a systems biology problem rather than a deficiency of any single molecule.
What Does This Mean for Functional Medicine?
Although recombinant BMP therapies remain largely confined to orthopedic surgery, this expanding understanding of BMP biology has broader implications.
Lifestyle factors that influence inflammation, mitochondrial function, stem cell health, oxidative stress, mechanical loading, and muscle mass may also indirectly influence BMP signaling.
Future therapeutic strategies may combine:
- Precision exercise programming
- Nutritional interventions
- Regenerative biologics
- Stem cell therapies
- Peptides
- Small molecules that modulate BMP signaling
Rather than replacing conventional orthopedic care, these approaches could potentially enhance the body’s own regenerative capacity.
Perhaps the most important takeaway from this review is that BMPs rarely work alone. The pathway interacts continuously with numerous signaling networks that functional medicine clinicians already recognize as central regulators of aging and chronic disease.
Looking Ahead
The authors conclude that BMP signaling represents one of the most promising therapeutic targets in musculoskeletal medicine. However, they also caution that considerable work remains before these discoveries translate into routine clinical care. Questions regarding dosing, timing, tissue specificity, receptor biology, and pathway interactions must all be resolved before targeted BMP therapies become widely available.
For integrative practitioners, the message is clear. Bone, cartilage, tendon, and muscle should no longer be viewed as independent tissues aging in parallel. They communicate continuously through highly coordinated signaling networks, with BMPs serving as one of the central conductors.
As research continues to unravel this biology, future musculoskeletal medicine may shift from treating structural damage after it occurs toward restoring the regenerative signaling networks that maintain healthy movement throughout life.
→ Download the Full Text here.
Related Podcast: More than Calcium and Minerals: Healthy Bone Tissue is the Foundation of Longevity
Reference
Chen B, Liu X, Hu M, Liao J. Insights into the bone morphogenetic protein signaling in musculoskeletal disorders: Mechanisms and crosstalk. J Orthop Translat. 2025 May 16;52:419-440. doi: 10.1016/j.jot.2025.03.005. PMID: 40485850; PMCID: PMC12145526.
